Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2022 Jan-Feb;37(1):61-72.
doi: 10.1016/j.nrl.2020.07.027. Epub 2020 Nov 5.

Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

[Article in English, Spanish]
E J Palacio-Portilla  1 , J Roquer  2 , S Amaro  3 , J F Arenillas  4 , O Ayo-Martín  5 , M Castellanos  6 , M M Freijo  7 , B Fuentes  8 , A García-Pastor  9 , M Gomis  10 , M Gómez-Choco  11 , E López-Cancio  12 , P Martínez-Sánchez  13 , A Morales  14 , M Rodríguez-Yáñez  15 , T Segura  5 , J Serena  16 , J Vivancos-Mora  17 , M A de Leciñana  8 ; Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología
Affiliations
Free article
Practice Guideline

Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

[Article in English, Spanish]
E J Palacio-Portilla et al. Neurologia (Engl Ed). 2022 Jan-Feb.
Free article

Abstract

Objective: We present an update of the Spanish Society of Neurology's recommendations for prevention of both primary and secondary stroke in patients with dyslipidaemia.

Development: We performed a systematic review to evaluate the main aspects of the management of dyslipidaemias in primary and secondary stroke prevention and establish a series of recommendations.

Conclusions: In primary prevention, the patient's vascular risk should be determined in order to define target values for low-density lipoprotein cholesterol. In secondary prevention after an atherothrombotic stroke, a target value <55mg/dL is recommended; in non-atherothombotic ischaemic strokes, given the unclear relationship with dyslipidaemia, target value should be established according to the vascular risk group of each patient. In both primary and secondary prevention, statins are the drugs of first choice, and ezetimibe and/or PCSK9 inhibitors may be added in patients not achieving the target value.

Keywords: Dislipidemia; Dyslipidaemia; Estatinas; Ictus; LDL cholesterol; LDL colesterol; Prevención; Prevention; Statins; Stroke.

PubMed Disclaimer

Publication types